Plus Therapeutics (PSTV) Misses Q4 EPS by 424c
Plus Therapeutics (NASDAQ: PSTV) reported Q4 EPS of ($4.24). Revenue for the quarter came in at $4.91 million.
For earnings history and earnings-related data on Plus Therapeutics (PSTV) click here.
Plus Therapeutics (NASDAQ: PSTV) reported Q4 EPS of ($4.24). Revenue for the quarter came in at $4.91 million.
For earnings history and earnings-related data on Plus Therapeutics (PSTV) click here.